Free · 13,591 studies indexed

lighttherapyresearch.com is a free index of research on photobiomodulation and light therapy, gathered from the world’s journals and trial registries.

Sections
Brain & Neurology

Low energy laser light (632.8 nm) suppresses amyloid-β peptide-induced oxidative and inflammatory responses in astrocytes

We demonstrated for the first time that 632.8 nm laser was capable of suppressing cellular pathways of oxidative stress and inflammatory responses critical in the pathogenesis in AD.

Excerpt from the paper’s abstract. Read the full paper for the details.

AI-generated summary

The authors studied primary rat astrocytes in cell culture, exposing them to 632.8 nm helium-neon laser light before treating them with oligomeric amyloid-beta peptide. They report that the laser suppressed amyloid-beta-induced superoxide production, NADPH oxidase subunit assembly, and expression of the inflammatory factors IL-1beta and iNOS. The authors suggest this could support future investigation of laser therapy for Alzheimer's disease.

Who or what was studied
Primary rat astrocytes in cell culture
Wavelengths
632 nm
Limits stated in the abstract
The study was performed in cultured cells, so the findings have not been tested in living humans or whole animals.

Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.

Abstract

The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.

Record from PubMed, a service of the National Library of Medicine.

How to read a single study: what to check before relying on this kind of research.

Terms in this paper: Laser, Oxidative stress, Inflammation. Each links to its definition in the glossary.

A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.

Related studies